ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
34
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,413
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Omalizumab and the risk of malignancy: Results from a pooled analysis
Author(s):
William Busse
,
Roland Buhl
,
Carlos Fernandez Vidaurre
,
Martin Blogg
,
Jin Zhu
,
Mark Eisner
,
Janice Canvin
Publication date:
2012-04-01
Journal:
Journal of Allergy and Clinical Immunology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Scientific Ocean Drilling Expedition Research Results
Author and article information
Journal
DOI::
10.1016/j.jaci.2012.01.033
PubMed ID::
22365654
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
5,413
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study
Authors:
Abrahim Abduelmula
,
Jorge R Georgakopoulos
,
Asfandyar Mufti
…
Response to omalizumab in patients with severe allergic asthma: A real-life study
Authors:
Louise Zierau
,
Emil Walsted
,
Simon Francis Thomsen
…
Long-term omalizumab use in the treatment of exercise-induced anaphylaxis
Authors:
Mark Peterson
,
Christopher A. Coop
See all similar
Cited by
31
Asthma Endotypes and an Overview of Targeted Therapy for Asthma
Authors:
Sarah Svenningsen
,
Parameswaran Nair
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
Authors:
Corrado Pelaia
,
Cecilia Calabrese
,
Rosa Terracciano
…
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review
Authors:
Martin Braddock
,
Nicola Hanania
,
Amir Sharafkhaneh
…
See all cited by
Version 1
- Current
Version 1